NCT05175001

Brief Summary

Chronic post-thoracotomy pain(CPTP)will not only have a negative impact on patients' physiology and psychology, but also affect postoperative recovery.A number of researches have demonstrated that Injury to the intercostal nerve during surgery predominantly accounts for the onset of CPTP.It is closely related to postoperative local acute inflammation and neuroinflammation. Thoracic paravertebral block (TPVB)has become a new trend for post-thoracotomy pain management.Glucocorticoids,as a adjuvant, are reported to prolong the effects of local anesthetic for peripheral nerve blocks.Diprospan is a long-acting glucocorticoid. It has been widely used in clinical treatment of various pain syndromes for powerful analgesic and anti-inflammatory effects. At present, most clinical reports are limited to the acute postoperative period, and there are few studies focusing on the long-term postoperative analgesic effect of diprospan.Therefore, it is reasonable for us to hypothesise diprospan, as a longer-acting glucocorticoid, can provide more lasting analgesic effects,or even reduce the incidence of CPTP

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for phase_4 chronic-pain

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 3, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2023

Completed
Last Updated

March 2, 2022

Status Verified

March 1, 2022

Enrollment Period

1.2 years

First QC Date

December 7, 2021

Last Update Submit

March 1, 2022

Conditions

Keywords

chronic painnerve block

Outcome Measures

Primary Outcomes (6)

  • Acute and chronic postoperative pain

    Numeric rating scale(NRS) is used to assess acute postoperative pain

    24 hours after surgery

  • Acute and chronic postoperative pain

    Numeric rating scale(NRS) is used to assess acute postoperative pain

    48 hours after surgery

  • Acute and chronic postoperative pain

    Numeric rating scale(NRS) is used to assess acute postoperative pain

    72 hours after surgery

  • Acute and chronic postoperative pain

    Numeric rating scale(NRS) is used to assess chronic postoperative pain

    1 month after surgery

  • Acute and chronic postoperative pain

    Numeric rating scale(NRS) is used to assess chronic postoperative pain

    3 months after surgery

  • Acute and chronic postoperative pain

    Numeric rating scale(NRS) is used to assess chronic postoperative pain

    6 months after surgery

Study Arms (2)

Group R

PLACEBO COMPARATOR

The patient is placed in lateral decubitus position with the operative side facing up, and the thoracic paravertebral nerve block will be performed under ultrasound. We select T4-5,T6-7and T8-9 intervertebral spaces for puncture.A 30-mL bolus of a solution of 0.33% ropivacaine in saline was administered under real-time ultrasound monitoring

Drug: Ropivacaine

Group RD

EXPERIMENTAL

The patient is placed in lateral decubitus position with the operative side facing up, and the thoracic paravertebral nerve block will be performed under ultrasound. We select T4-5,T6-7and T8-9 intervertebral spaces for puncture.A 30-mL bolus of a solution of 0.33% ropivacaine plus 4.67mg Diprospan in saline was administered under real-time ultrasound monitoring

Drug: Diprospan

Interventions

Diprospan combined with ropivacaine in ultrasound-guided thoracic paravertebral nerve block

Also known as: Compound Betamethasone Injection
Group RD

Only ropivacaine in ultrasound-guided thoracic paravertebral nerve block

Group R

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-70 years
  • American Society of Anesthesiologists(ASA) physical status of I-III
  • BMI: 18.5-28 kg/m2
  • Type of operation: elective thoracoscopic lobectomy
  • The patient and/or family members have signed the informed consent -

You may not qualify if:

  • Allergic to local anesthetics or glucocorticoids
  • Preoperative use of opioids
  • Severe coagulation dysfunction
  • Severe heart, lung, liver and kidney insufficiency
  • Used to have immunosuppressive therapies such as radiotherapy, chemotherapy and glucocorticoid, or have immune system diseases
  • Peptic ulcer
  • Perform astrointestinal anastomosis recently
  • Used to have a chest surgery
  • Central nervous system disease or peripheral neuropathy
  • Perioperative blood transfusion
  • Others: such as fracture, wound repair, corneal ulcer, adrenal hypercortical disease, diabetes, pregnant women -

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Nantong University

Nantong, Jiangsu, 226000, China

RECRUITING

Related Publications (4)

  • Zhang YK, Yang H, Zhang JY, Song LJ, Fan YC. Comparison of intramuscular compound betamethasone and oral diclofenac sodium in the treatment of acute attacks of gout. Int J Clin Pract. 2014 May;68(5):633-8. doi: 10.1111/ijcp.12359. Epub 2014 Jan 29.

  • Marty P, Bennis M, Legaillard B, Cavaignac E, Ferre F, Lebon J, Brouchet A, Minville V. A New Step Toward Evidence of In Vivo Perineural Dexamethasone Safety: An Animal Study. Reg Anesth Pain Med. 2018 Feb;43(2):180-185. doi: 10.1097/AAP.0000000000000392.

  • Watanabe K, Tokumine J, Yorozu T, Moriyama K, Sakamoto H, Inoue T. Particulate-steroid betamethasone added to ropivacaine in interscalene brachial plexus block for arthroscopic rotator cuff repair improves postoperative analgesia. BMC Anesthesiol. 2016 Oct 4;16(1):84. doi: 10.1186/s12871-016-0251-9.

  • Wang QS, Jiang YH, Wang TD, Xiao T, Wang JK. Effects of betamethasone on neuropathic pain in a rat spare nerve injury model. Clin Exp Pharmacol Physiol. 2013 Jan;40(1):22-7. doi: 10.1111/1440-1681.12027.

MeSH Terms

Conditions

Chronic Pain

Interventions

betamethasone dipropionate, betamethasone sodium phosphate drug combinationRopivacaine

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Yibin Qin, Associate chief physician

    Affiliated Hospital of Nantong University

    STUDY DIRECTOR

Central Study Contacts

Yibin Qin, Associate chief physician

CONTACT

Mengru Cui, Resident

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
None of the participants know which group they were in,neither of the investigators and outcomes assessor.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The patient is placed in lateral decubitus position with the operative side facing up, and the thoracic paravertebral nerve block will be performed under ultrasound. We select T4-5,T6-7and T8-9 intervertebral spaces for puncture.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate chief physician

Study Record Dates

First Submitted

December 7, 2021

First Posted

January 3, 2022

Study Start

May 1, 2021

Primary Completion

June 30, 2022

Study Completion

January 30, 2023

Last Updated

March 2, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations